Ingelheim, Germany, July 7, 2025 – Boehringer Ingelheim today announces the start of the THULITE Phase II clinical study ( NCT06962839 ). It will investigate the efficacy, safety and tolerability of BI 1815368 as a potential oral treatment to ...
PR Newswire WASHINGTON, July 9, 2025 Youth Delegates Living with Type 1 Diabetes and Katie Bone, American Ninja Warrior Champion Who Lives with Type 1 Diabetes Provided Testimony at a Senate Appropriations Committee Hearing More than 1.5 ...
PR Newswire LONDON, June 28, 2025 LONDON, June 28, 2025 /PRNewswire/ -- A team of international scientists has made a major leap forward in diabetes research by successfully 3D printing functional human islets using a novel bioink. Presented ...
Canada NewsWire OTTAWA, ON, June 27, 2025 OTTAWA, ON, June 27, 2025 /CNW/ - Summary IssueHealth Canada is warning people with diabetes and their caregivers that numerous unauthorized blood glucose monitors are being sold through ...
PR Newswire COPENHAGEN, Denmark, June 24, 2025 COPENHAGEN, Denmark, June 24, 2025 /PRNewswire/ -- Breye Therapeutics ApS (Breye), a clinical-stage ophthalmology focused biopharmaceutical company developing oral therapeutics for the early ...
PR Newswire SUZHOU, China, June 23, 2025 SUZHOU, China, June 23, 2025 /PRNewswire/ -- BrightGene Pharmaceutical Co., Ltd., an international, innovation-driven pharmaceutical company, presented data from two Phase 2 studies for BGM0504, its ...
PR Newswire CHICAGO, June 23, 2025 Study Results Signal Paradigm Shift in Diabetes Care for Patients with Difficult-to-Control Type 2 Diabetes CHICAGO, June 23, 2025 /PRNewswire/ -- New findings from the CATALYST study show that the use ...
PR Newswire CHICAGO, June 22, 2025 Oral formulation demonstrates comparable cardiovascular benefits to injectable GLP-1s CHICAGO, June 22, 2025 /PRNewswire/ -- A recent study found that oral semaglutide offers meaningful cardiovascular ...
PR Newswire CHICAGO, June 22, 2025 Once-weekly insulin helped patients achieve an average A1C of 6.92% in QWINT-1 trial Results support once-weekly insulin as effective alternative to daily treatment CHICAGO, June 22, 2025 ...
PR Newswire CHICAGO, June 21, 2025 This challenge Kickstarts additional investments through the new ADA Innovation Fund CHICAGO, June 21, 2025 /PRNewswire/ -- As the American Diabetes Association® (ADA) celebrates its 85th anniversary, ...
Presence of high blood sugar in diabetic patients boosts cavity causing bacteria in saliva and significantly increases the risk of dental cavities.
A distinct type of immune cells was found in pancreas of type 1 diabetic people; the discovery offers target for early detection and prevention of diabetes.
WHO releases its first global guidelines for diabetes in pregnancy, aiming to prevent life-threatening complications and improve outcomes for millions of mothers and babies.
Workplace stress, long hours, and unhealthy habits are raising diabetes risk among India’s young professionals. Awareness and lifestyle changes are key.
Researchers found patients on GLP-1 drugs were less than half as likely to die within five years, hinting at a powerful new link between metabolic health and cancer survival.
MEDINDIA
English
हिन्दी
Español
français
中文